Latest Market News

Xenitra Limited’s OPAL Real World Asset tokenised sales ecosystem has accelerated rapidly, crossing $1.1 million in product sales and onboarding over 400 distribution partners within seven weeks, signalling strong traction in Greater China.

IperionX’s Definitive Feasibility Study for its Titan Project in Tennessee reveals a robust 14-year mine plan producing critical heavy rare earths, titanium minerals, and zircon with strong financial returns and US government backing.

Chrysos Corporation has refinanced its debt with a $200 million syndicated facility, enhancing financial flexibility to accelerate manufacturing and deployment of its PhotonAssay technology worldwide.

Island Pharmaceuticals has kicked off GMP manufacturing of its antiviral Galidesivir to support late-stage Marburg virus studies under the FDA Animal Rule, marking a key step towards regulatory submission and biodefence readiness.

First Graphene accelerates its US expansion by acquiring MITO Material Solutions, gaining functionalised graphene technologies and a direct commercial foothold in the world’s largest defence and aerospace market.

Breakthrough Minerals has revealed promising initial assay results from its maiden diamond drilling at the Barbara Copper-Gold Project, highlighting high-grade copper mineralisation and significant resource expansion potential within and beyond current boundaries.

Racura Oncology has secured $31.2 million in funding to advance its lead cancer drug RC220, including a strategic $1 million private placement to a specialist healthcare investor.

Urbanise is set to launch a unified strata payments platform integrated with NAB banking, promising streamlined workflows and a branded owners portal from July 2026.

Optiscan Imaging has reached the halfway recruitment milestone in its first in-human breast cancer study, advancing its regulatory and commercial ambitions with promising clinical data and expanded trial sites.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.

Propel Funeral Partners has inked deals for three New Zealand funeral service providers, adding nearly $4 million in revenue and projecting modest growth for FY26 despite currency headwinds.

Pro Medicus' U.S. subsidiary Visage Imaging has extended its contract with The Ohio State University Wexner Medical Center for five years, adding new Visage 7 modules and increasing transaction fees, underpinning strong client retention and platform demand.